Pacylex Pharmaceuticals Presents New Data on the Mechanism of Action of Myristoylation Inhibition
A myristoylation inhibition gene expression signature, MISS-91 (Myristoylation Inhibitors Sensitivity Signature), will be presented at the European Association for Cancer Research (EACR) 2023 Congress.
Pacylex Pharmaceuticals Reports a Potential Drug Sensitivity Gene Signature and the Effects of Myristoylation Inhibition on Angiogenesis and Cancer Cell Migration at American Association of Cancer Research (AACR) 2023.
